[PET in head and neck cancers].

Area of Science:

• Oncology
• Nuclear Medicine
• Radiology

Background:

• FDG PET is a valuable imaging tool for head and neck cancers.
• Accurate characterization of salivary gland tumors with FDG PET remains a challenge.
• PET/CT fusion improves anatomical landmark identification in the head and neck region.

Purpose of the Study:

• To evaluate the utility of FDG PET in diagnosing and managing head and neck cancers.
• To assess the role of FDG PET in predicting chemotherapy response.
• To determine the effectiveness of FDG PET in monitoring cancer recurrence and for restaging.

Main Methods:

• Utilized FDG PET imaging for diagnosis, staging, and treatment monitoring.
• Employed PET/CT fusion to enhance anatomical localization.
• Assessed changes in FDG uptake to evaluate chemotherapy efficacy.
• Considered timing of FDG PET post-treatment to avoid false positives from inflammation.

Main Results:

• FDG PET can detect suspicious lymph nodes, distant metastases, and second cancers.
• Absence of reduced FDG uptake after early chemotherapy cycles predicts treatment failure.
• Disappearance of FDG uptake indicates treatment effectiveness but does not exclude residual disease.
• FDG PET is most impactful for monitoring recurrence and restaging.

Conclusions:

• FDG PET, particularly with CT fusion, is beneficial for head and neck cancer management.
• Early assessment of FDG uptake can guide chemotherapy regimen adjustments.
• FDG PET plays a crucial role in surveillance for recurrence, with optimal timing requiring further definition.
• The role of FET PET in squamous cell carcinoma warrants further investigation.